Ser-Leu integrates a polar serine with hydrophobic leucine, producing an amphipathic system for examining hydrogen bonding and solvent interactions. The dipeptide supports modeling of secondary-structure initiation. Researchers evaluate its behavior in enzymatic recognition studies. Applications span peptide assembly research, motif analysis, and conformational profiling.
CAT No: R2663
CAS No:6665-16-3
Synonyms/Alias:Ser-Leu;H-Ser-Leu-OH;6665-16-3;seryl-leucine;L-seryl-L-leucine;serylleucine;Serinylleucine;SL dipeptide;S-L Dipeptide;CHEBI:74815;Serine Leucine dipeptide;Serine-Leucine dipeptide;(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoic acid;L-Leucine, L-seryl-;DTXSID60875837;N-Serylleucine;Serinyl-Leucine;(2S)-2-(((2S)-2-amino-3-hydroxypropanoyl)amino)-4-methylpentanoic acid;(2S)-2-(((2S)-2-azaniumyl-3-hydroxypropanoyl)amino)-4-methylpentanoate;(2S)-2-[[(2S)-2-azaniumyl-3-hydroxypropanoyl]amino]-4-methylpentanoate;MFCD00055934;L-Ser-L-Leu;L-Serinyl-L-Leucine;N-L-Seryl-L-leucine;CHEMBL52406;SCHEMBL3777970;DTXCID901013954;SL;DA-74289;FS108174;Q27144925;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More